Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al
Case Number:
2:22-cv-00223
Court:
Nature of Suit:
Other Statutes: Administrative Procedure Act/Review or Appeal of Agency Decision
Judge:
Firms
- American Center for Law & Justice Inc.
- Bustos Law Firm PC
- Covington & Burling
- Debevoise & Plimpton
- Fillmore Law Firm
- Hogan Lovells
- McCarn & Weir
- Morgan Williamson
- Mullin Hoard
- Perdue Brandon
- Samples Jennings
- Sheppard Mullin
- Shutts & Bowen
- Smith Appellate Law Firm
- Weycer Kaplan
Companies
- American Academy of Family Physicians
- American Medical Association Inc.
- Charlotte Lozier Institute
- Judicial Watch Inc.
Government Agencies
Sectors & Industries:
-
March 13, 2023
Judge Goes Public With Abortion Hearing Info After Outcry
A Texas federal judge on Monday docketed a hearing for a suit filed by anti-abortion activists bent on forcing the U.S. Food and Drug Administration to rescind abortion drug approvals, hours after reporters and media outlets published a letter accusing him of violating the U.S. Constitution by keeping the hearing schedule secret.
-
February 23, 2023
Abortion Pill Fate Hangs On Conservative Judge, 'Zombie' Law
A legal battle threatening to invalidate the federal government's decades-old approval of the leading abortion medication may come down to whether a Texas federal judge appointed by former President Donald Trump agrees with anti-abortion activists' argument that a 150-year-old anti-vice law makes it unlawful to mail abortion drugs.
-
February 10, 2023
Red And Blue State AGs Join Legal Fight Over Abortion Pill
Attorneys general in red and blue states picked sides Friday in a legal battle that could dramatically restrict abortion access in the U.S. if a Texas federal judge grants anti-abortion activists' bid to block the U.S. Food and Drug Administration's decades-old approval of the abortion medication mifepristone.
-
January 17, 2023
FDA Urges Texas Judge Not To Reverse Abortion Pill Approval
The U.S. Food and Drug Administration has urged a Texas federal judge to reject anti-abortion groups' bid to block FDA approvals of the abortion medication mifepristone, saying that an injunction would block patient access to a safe and effective drug that has been on the market for over two decades.
-
January 02, 2023
Health Care & Life Sciences Litigation To Watch In 2023
Before the New Year's Eve confetti has even been swept up, lawyers specializing in health care and life sciences already have enough litigation to keep them busy for much of 2023, which is kicking off with federal courts eyeing suits that carry sweeping significance for administrative law, the False Claims Act, drug approvals, the opioid crisis and abortion rights.
-
November 18, 2022
FDA Faces Texas Suit Over Approval Of Abortion Drugs
The U.S. Food and Drug Administration was hit with a lawsuit in Texas federal court Friday from anti-abortion groups that want the agency to be forced to rescind approvals for abortion drugs.
- ← Previous
- 1
- 2
- Next →